abstract |
Inhibiting leucotriene synthesis in patients with novel substituted N-(quinolin-2-yl-methoxy)benzylsulphonyl-urea of the formula ##STR1## in which A, B, D, E, G, K and M each independently is H, OH, halogen, CF 3 , OCF 3 , COOH, alkyl, alkoxy, alkoxycarbonyl or aryl, n R 1 is alkyl or cycloalkyl, n R 2 and R 3 each independently is H or alkyl, and n R 4 is alkyl, aryl or a heterocyclic radical, n and salts thereof. |